Dermatol. praxi. 2016;10(3):106-110 | DOI: 10.36290/der.2016.026

Current possibilities of treatment of atopic eczema

MUDr. Štěpánka Čapková
Dermatologické oddělení pro děti, FN Motol, Praha

Atopic eczema (AE) is a chronic, inflammatory skin disorder. In spite of intensive investigations, the causes of AE remain uncelar, but are likely to be multifactorial in nature. Among various measures of AE managment skin hydration, which improves barrier function and relieve itchiness, may be helpful to reduce the need for topical steroid use and therefore it should be used as a basic treatment. Avoiding aggravating factors is also a basic treatment of AE. Standard medical treatment with a pharmacologic approach may be necessary if basic treatment fails to control symptoms sufficiently. Recently,more attention is given to proactive treatment regimen by regular intermittent application of topical corticosteroids or topical calcineurin inhibitors to prevent new flares. Furthermore, various targeted bilogics are being introduced for AE control and are proposed to represent promising therapies.

Keywords: atopic eczema, reviews of treatments, cleansing and bathing, emollients, topical anti-inflammatory therapy, systemic

Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čapková Š. Current possibilities of treatment of atopic eczema. Dermatol. praxi. 2016;10(3):106-110. doi: 10.36290/der.2016.026.
Download citation

References

  1. Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I, Part II JEADV 2012; 26: 1045-1060. Go to original source... Go to PubMed...
  2. Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis. Section 2. J Am Acad Dermatol 2014; 71(1): 116-132. Go to original source... Go to PubMed...
  3. Gelmetti C, Wollenberg A. Atopic dermatitis - all you can do from the outside. British Journal of Dermatology 2014; 170(Suppl. S1): 19-24. Go to original source... Go to PubMed...
  4. Silverberg J I. Atopic Dermatitis: An Evidence-Based Treatment Update. AM J Clin Dermatol 2014, DOI 10.1007/s40257-014-0062-z. Go to original source... Go to PubMed...
  5. Eichenfield LF, Boguniewicz M, Simpson EL, et al. Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers. PEDIATRICS Volume 2015; 136(3): 1-12. Go to original source... Go to PubMed...
  6. Wollenberg A, Oranje A, Deleuran M, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. JEADV 2016; 30: 729-747. Go to original source... Go to PubMed...
  7. Lee JH, Son SW, Cho SH. A Comprehensive Review of the Treatment of Atopic Eczema, Allergy Asthma Immunol Res 2016; 8(3): 181-190. Go to original source... Go to PubMed...
  8. Katayama I, Kohno Y, Akiyama K, et al. Japanese Guideline for Atopic Dermatitis 2014, Allergology International 2014; 63(3): 377-398. Go to original source...
  9. Moustafa F, Feldman SR. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. Dermatol Online J. 2014; 20(5): 22608. PMID 24852768. Go to original source...
  10. Eyerich K, Eyerich S, Biedermann T. The Multi-Modal Immune Pathogenesis of Atopic Eczema. Trends in Immunology, December 2015; Vol. 36, No.12. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.